PREPARATION AND EVALUATION OF GASTRORETENTIVE FLOATING MATRIX TABLETS OF CLARITHROMYCIN
Main Article Content
Abstract
In the present research work gastro retentive floating matrix formulation of Clarithromycin by using various hydrophilic polymers were developed. Initially analytical method development was done for the drug molecule. Absorption maxima was determined based on that calibration curve was developed by using different concentrations. Gas generating agent sodium bicarbonate concentration was optimized. Then the formulation was developed by using different concentrations of polymers of various grades of HPMC as polymeric substances. The formulation blend was subjected to various pre-formulation studies, flow properties and all the formulations were found to be good indicating that the powder blend has good flow properties. Among all the formulations the formulations HPMC K15M as polymer were retarded the drug release up to desired time period i.e., 12 hours in the concentration of 180 mg. whereas in low concentrations the polymer was unable to produce the desired action. (F3 Formulation, 98.56% Drug release). The formulations prepared with HPMC K100M were also retarded the drug release for more than 12 hours. Hence, they were not considered. The optimized formulation dissolution data was subjected to release kinetics, from the release kinetics data it was evident that the formulation followed zero order mechanism of drug release.
Downloads
Article Details

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
How to Cite
References
Ansel, Pharmaceutical Dosage form and Drug Delivery System, Lipincott, 7th edition: P. 553.
Banker G.S, Rhodes C.T, Modern Pharmaceutics. 3rd ed. Marcel Dekker, New York: (1996) P.678-721.
Brahmankar D.M, Jaiswal S.B, Biopharmaceutics and Pharmacokinetics a treatise, 1st ed. Vallabh prakashan; New Delhi: (1995) P.64-70.
Chein Y.W, Novel Drug Delivery Systems, 2nd ed.: Marcel Dekker; New York: (1992) P.4-56.
Desai S, Bolton S. A Floating Controlled Release System: In-vitro and In-vivo evaluation, J. Pharm. Res., (1993): 10; P.1321-1325.
Dr.Jose, Khalid Shah, Gastroretentive Drug Delivery System, Business brief, Pharmtech., (2003) P. 165-173.
Garg S, Sharma S. Gastroretentive Drug Delivery Systems, Pharmatech, (2003): P.160-164.
Garima Chawla, Gupta, Pharmaceutical technology, July (2003): 23(9); P.39-48.
Gennaro R.A. Remington,The Science and Practice of Pharmacy., 20th ed. New york : Lippincott Williams: (2000) P.1045.
Leon Lachman, Herbert A. Liberman, the Theory and Practice of Industrial Pharmacy: P.293-302.
Libo Yang, A New Intragastric Delivery System for the Treatment of H.Pylori associated with gastric ulcers, Elsevier J. of controlled release., Apr(1999): 34 (5); P. 215-222.
P.G.Yeole, Floating Drug Delivery System: Need and Development, Ind. J. Pharm Sci., (2005): 67(3); 265-272.
Robinson Jr, Lee V.H.L, Controlled drug delivery: Fundamentals and Applications, 2nd edn. Marcel Dekker, New york: (1978) P.24-36.
Ross and Wilson, Anatomy Physiology and Health Education. 9th ed. Churchil Livingston, P. 295-311.
Shweta Arora, Floating Drug Delivery: A Review, AAPS Pharmscitech., (2005): 47(11); P.268-272.
Vyas S.P, Khar R.K, Controlled Drug Delivery: Concepts and Advances, 1st ed. Vallabh prakashan, New Delhi: (2002) P.345-376.
Wilson K.R.W, Waugh A. Anatomy and physiology in Health and Illness, 9th ed. Churchill Livingstone: London: (1996). P. 342-345.